| TAF11 |
TAF11, TAF2I, PRO2134: Transcription initiation factor TFIID subunit 11 |
TAF7 |
TAF7, TAF2F, TAFII55: Transcription initiation factor TFIID subunit 7 |
10.330 |
Evidence |
|
| VDR |
VDR, NR1I1: Vitamin D3 receptor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
10.300 |
Evidence |
O
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
10.300 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
10.300 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
10.300 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
10.300 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
EWSR1 |
EWSR1, EWS: RNA-binding protein EWS |
10.240 |
Evidence |
|
| STAMBP |
STAMBP, AMSH: STAM-binding protein |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
10.220 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
10.180 |
Evidence |
O
|
| RANBP5 |
|
KPNA6 |
IPI00155940 |
10.180 |
Evidence |
O
|
| PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
TRAF6 |
TRAF6, RNF85: TNF receptor-associated factor 6 |
10.160 |
Evidence |
O
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
MCM5 |
MCM5, CDC46: DNA replication licensing factor MCM5 |
10.160 |
Evidence |
|
| HARS |
HARS, HRS: Histidyl-tRNA synthetase, cytoplasmic |
EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
10.160 |
Evidence |
|
| SUV39H1 |
SUV39H1, SUV39H: Histone-lysine N-methyltransferase SUV39H1 |
CBX1 |
CBX1, CBX: Chromobox protein homolog 1 |
10.160 |
Evidence |
O
|
| TAF4 |
TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135: Transcription initiation factor |
TAF9 |
TAF9, TAF2G, TAFII31: Transcription initiation factor TFIID subunit 9 |
10.160 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
10.120 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
10.100 |
Evidence |
O
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
10.100 |
Evidence |
O
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
10.100 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
10.090 |
Evidence |
|
| MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
10.060 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
CSK |
CSK: Tyrosine-protein kinase CSK |
10.060 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
CTGF |
CTGF, CCN2, HCS24: Connective tissue growth factor precursor |
10.060 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
10.020 |
Evidence |
O
|
| PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
ACTN1 |
ACTN1: Alpha-actinin-1 |
10.010 |
Evidence |
|
